Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats

The use of progestins as a component of hormone replacement therapy has been linked to an increase in breast cancer risk in postmenopausal women. We have previously shown that medroxyprogesterone acetate (MPA), a commonly administered synthetic progestin, increases production of the potent angiogeni...

Full description

Saved in:
Bibliographic Details
Main Authors: Mafuvadze, Benford, Benakanakere, Indira, Lopez, Franklin, Besch-Williford, Cynthia, Ellersieck, Mark R., Hyder, Salman M.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3151306/
https://ncbi.nlm.nih.gov/pubmed/21505181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-10-0382
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items